Studies Presented at European Society of Cardiology Congress

JAMA

EMBARGOED FOR RELEASE: 2:30 A.M. (ET), MONDAY, SEPTEMBER 2, 2019

Media advisory: The studies and editorials linked to this news release were released to coincide with presentation at the European Society of Cardiology Congress 2019 in Paris.

Embed these links to provide your readers free access to the full-text articles These links will be live at the embargo time

 

Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.14231?guestAccessKey=135a92ef-8e23-4dc5-90f4-17100351f107&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090219

 

Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.12821?guestAccessKey=5bd0d473-87aa-4e77-9027-a9e544274e8e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090219

 

Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.12843?guestAccessKey=61134750-7788-47bb-bcd9-81c3b1f51ede&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090219

 

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations